BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats

This study determined if blocking ligand occupancy of the αVβ3 integrin could inhibit the pathophysiologic changes that occur in the early stages of diabetic nephropathy (DN). Diabetic rats were treated with either vehicle or a monoclonal antibody that binds the β3 subunit of the αVβ3 integrin. Afte...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura A. Maile, Katherine Gollahon, Christine Wai, Paul Dunbar, Walker Busby, David Clemmons
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2014/421827
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568333702004736
author Laura A. Maile
Katherine Gollahon
Christine Wai
Paul Dunbar
Walker Busby
David Clemmons
author_facet Laura A. Maile
Katherine Gollahon
Christine Wai
Paul Dunbar
Walker Busby
David Clemmons
author_sort Laura A. Maile
collection DOAJ
description This study determined if blocking ligand occupancy of the αVβ3 integrin could inhibit the pathophysiologic changes that occur in the early stages of diabetic nephropathy (DN). Diabetic rats were treated with either vehicle or a monoclonal antibody that binds the β3 subunit of the αVβ3 integrin. After 4 weeks of diabetes the urinary albumin to creatinine ratio (UACR) increased in both diabetic animals that subsequently received vehicle and in the animals that subsequently received the anti-β3 antibody compared with control nondiabetic rats. After 8 weeks of treatment the UACR continued to rise in the vehicle-treated rats; however it returned to levels comparable to control nondiabetic rats in rats treated with the anti-β3 antibody. Treatment with the antibody prevented the increase of several profibrotic proteins that have been implicated in the development of DN. Diabetes was associated with an increase in phosphorylation of the β3 subunit in kidney homogenates from diabetic animals, but this was prevented by the antibody treatment. This study demonstrates that, when administered after establishment of early pathophysiologic changes in renal function, the anti-β3 antibody reversed the effects of diabetes normalizing albuminuria and profibrotic proteins in the kidney to the levels observed in nondiabetic control animals.
format Article
id doaj-art-0951f397a7bd4bd98163ee2a114df569
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-0951f397a7bd4bd98163ee2a114df5692025-02-03T00:59:14ZengWileyJournal of Diabetes Research2314-67452314-67532014-01-01201410.1155/2014/421827421827BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic RatsLaura A. Maile0Katherine Gollahon1Christine Wai2Paul Dunbar3Walker Busby4David Clemmons5Department of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USADepartment of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USADepartment of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USADepartment of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USADepartment of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USADepartment of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USAThis study determined if blocking ligand occupancy of the αVβ3 integrin could inhibit the pathophysiologic changes that occur in the early stages of diabetic nephropathy (DN). Diabetic rats were treated with either vehicle or a monoclonal antibody that binds the β3 subunit of the αVβ3 integrin. After 4 weeks of diabetes the urinary albumin to creatinine ratio (UACR) increased in both diabetic animals that subsequently received vehicle and in the animals that subsequently received the anti-β3 antibody compared with control nondiabetic rats. After 8 weeks of treatment the UACR continued to rise in the vehicle-treated rats; however it returned to levels comparable to control nondiabetic rats in rats treated with the anti-β3 antibody. Treatment with the antibody prevented the increase of several profibrotic proteins that have been implicated in the development of DN. Diabetes was associated with an increase in phosphorylation of the β3 subunit in kidney homogenates from diabetic animals, but this was prevented by the antibody treatment. This study demonstrates that, when administered after establishment of early pathophysiologic changes in renal function, the anti-β3 antibody reversed the effects of diabetes normalizing albuminuria and profibrotic proteins in the kidney to the levels observed in nondiabetic control animals.http://dx.doi.org/10.1155/2014/421827
spellingShingle Laura A. Maile
Katherine Gollahon
Christine Wai
Paul Dunbar
Walker Busby
David Clemmons
BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
Journal of Diabetes Research
title BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
title_full BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
title_fullStr BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
title_full_unstemmed BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
title_short BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
title_sort blockingαvβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats
url http://dx.doi.org/10.1155/2014/421827
work_keys_str_mv AT lauraamaile blockingavb3integrinligandoccupancyinhibitstheprogressionofalbuminuriaindiabeticrats
AT katherinegollahon blockingavb3integrinligandoccupancyinhibitstheprogressionofalbuminuriaindiabeticrats
AT christinewai blockingavb3integrinligandoccupancyinhibitstheprogressionofalbuminuriaindiabeticrats
AT pauldunbar blockingavb3integrinligandoccupancyinhibitstheprogressionofalbuminuriaindiabeticrats
AT walkerbusby blockingavb3integrinligandoccupancyinhibitstheprogressionofalbuminuriaindiabeticrats
AT davidclemmons blockingavb3integrinligandoccupancyinhibitstheprogressionofalbuminuriaindiabeticrats